EX-10.18 18 dex1018.htm FORM OF PLEDGE AGREEMENT PLEDGE AGREEMENTPledge Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS PLEDGE AGREEMENT, dated as of November 17, 2010 (this “Agreement”), is made by Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Pledgor”), in favor of the holders (the “Holders” or the “Pledgees”) of the 8.50% Secured Convertible Debentures Due May 17, 2012 (collectively, the “Debentures”) issued by Pledgor to the Holders.
PLEDGE AGREEMENTPledge Agreement • February 11th, 2011 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 11th, 2011 Company Industry JurisdictionTHIS PLEDGE AGREEMENT, dated as of November 17, 2010 (this “Agreement”), is made by Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Pledgor”), in favor of the holders (the “Holders” or the “Pledgees”) of the 8.50% Secured Convertible Debentures Due May 17, 2012 (collectively, the “Debentures”) issued by Pledgor to the Holders.
PLEDGE AGREEMENTPledge Agreement • October 2nd, 2006 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 2nd, 2006 Company Industry JurisdictionPLEDGE AGREEMENT (this “Agreement”), dated as of September 29, 2006, made by Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Pledgor”), in favor of the holders (the “Holders” or the “Pledgees”) of the Pledgor’s 8% Secured Convertible Debentures due September , 2010 issued by Pledgor (the “Debentures”).